Stay updated with breaking news from Initial Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
.jpg)
Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase III Coronavirus Efficacy (COVE) clinical trial find the Moderna vaccine reduces severe acute respiratory coronavirus 2 (SARS-CoV-2) viral load and viral shedding.
This blog post distills learning from roundtables connecting anti-money laundering professionals with conservation practitioners to seek touchpoints and identify information gaps.